Morris, D L <br/><br/>
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma.  [electronic resource] 

 -  Cancer  May 1996 
 - 1956-7 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-0142(19960501)77:9<1956::AID-CNCR29>3.0.CO;2-Y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Carcinoma--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Colonic Neoplasms--drug therapy<br/>Hormone Antagonists--administration & dosage<br/>Humans<br/>Neoplasm Staging<br/>Octreotide--administration & dosage<br/>Rectal Neoplasms--drug therapy<br/>Somatostatin--administration & dosage<br/>Survival Rate